Association of low levels of first trimester Pregnancy Associated Plasma Protein (PAPP-A) with adverse pregnancy outcomes: An observational study

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.15761/OGR.1000116
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Maternal serum PAPP‐A and free β‐hCG at 12, 22 and 32 weeks' gestation in screening for pre‐eclampsia

  2016cited by this paper
• Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes

  2014cited by this paper
• Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting.

  2013influential reference
• First trimester serum analytes, maternal characteristics and ultrasound markers to predict pregnancies at risk for preterm birth.

  2013cited by this paper
• Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11–13 weeks

  2011cited by this paper
• First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia.

  2011cited by this paper
• PAPP‐A, free β‐hCG, and early fetal growth identify two pathways leading to preterm delivery

  2010cited by this paper
• Maternal plasma soluble endoglin at 11–13 weeks' gestation in pre‐eclampsia

  2010cited by this paper
• Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP‐A at 11–13 weeks

  2010influential reference
• First‐trimester maternal serum pregnancy‐associated plasma protein‐A and pre‐eclampsia

  2009cited by this paper
• First‐trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery

  2008cited by this paper
• First‐trimester biochemical markers of aneuploidy and the prediction of small‐for‐gestational age fetuses

  2008cited by this paper
• Screening for placental insufficiency in high-risk pregnancies: is earlier better?

  2008cited by this paper
• First‐trimester screening for trisomy 21 by free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A: impact of maternal and pregnancy characteristics

  2008cited by this paper
• Low levels of maternal serum PAPP‐A in early pregnancy and the risk of adverse outcomes

  2008cited by this paper
• The insulin-like growth factor system and fetal growth restrictionn.

  2008cited by this paper
• Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes.

  2004cited by this paper
• First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).

  2004influential reference
• Predicting complications of pregnancy with first‐trimester maternal serum free‐βhCG, PAPP‐A and inhibin‐A

  2003cited by this paper
• Decreased first trimester PAPP‐A is a predictor of adverse pregnancy outcome

  2002cited by this paper
• Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth.

  2002cited by this paper
• The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)

  2001cited by this paper
• Pregnancy-associated Plasma Protein-A2 (PAPP-A2), a Novel Insulin-like Growth Factor-binding Protein-5 Proteinase*

  2001cited by this paper
• Pregnancy‐associated plasma protein‐A (PAPP‐A) cleaves insulin‐like growth factor binding protein (IGFBP)‐5 independent of IGF: implications for the mechanism of IGFBP‐4 proteolysis by PAPP‐A

  2001cited by this paper
• First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications

  2000cited by this paper
• The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A.

  1999cited by this paper
• Role of the IGF system in trophoblast invasion and pre-eclampsia.

  1999cited by this paper
• Maternal serum levels of free β‐hCG and PAPP‐A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery

  1998cited by this paper
• Role of insulin-like growth factor binding proteins in controlling IGF actions.

  1998cited by this paper
• The IGF system during fetal-placental development of the mouse.

  1998cited by this paper
• UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.

  1998cited by this paper
• Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities

  1996cited by this paper
• Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy

  1995cited by this paper
• Maternal Serum Pregnancy-Associated Plasma Protein A and Fetal Nuchal Translucency Thickness for the Prediction of Fetal Trisomies in Early Pregnancy

  1994cited by this paper
• Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta.

  1994cited by this paper
• Low maternal serum levels of pregnancy associated plasma protein A (PAPP‐A) in the first trimester in association with abnormal fetal karyotype

  1993cited by this paper
• Reduced circulating placental protein concentrations during the first trimester are associated with preterm labour and low birth weight.

  1993cited by this paper
• Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small‐for‐gestational‐age infants

  1987cited by this paper
• The localization of pregnancy proteins (hPL, SP1 and PAPP-A) in intra- and extrauterine pregnancies.

  1984cited by this paper
• Human seminal plasma contains a protein that shares physicochemical, immunochemical, and immunosuppressive properties with pregnancy-associated plasma protein-A.

  1983cited by this paper
• Tissue and plasma concentrations of pregnancy‐associated plasma protein‐A (PAPP‐A): comparison with other fetoplacental products

  1982cited by this paper
• Measurement of pregnancy-associated plasma proteins during human gestation.

  1974cited by this paper
• Three pregnancy-associated human plasma proteins: purification, monospecific antisera and immunological indentification.

  1974cited by this paper
• © Institute of Mathematical Statistics, 2004 LEAST ANGLE REGRESSION

  year unknowncited by this paper

• Relationship between extreme values of first trimester maternal pregnancy associated plasma Protein-A, free-β-human chorionic gonadotropin, nuchal translucency and adverse pregnancy outcomes.

  2022cites this paper
• Role of pregnancy-associated plasma protein A (PAPP-A) and human-derived chorionic gonadotrophic hormone (free β-hCG) serum levels as a marker in predicting of Small for gestational age (SGA): A cohort study

  2021cites this paper
• Clinical Importance of Low Level of PAPP-A in First Trimester of Pregnancy - An Obstetrical Dilemma in Chromosomally Normal Fetus

  2019cites this paper
• Assessment of β-human-derived chorionic gonadotrophic hormone (βhCG) and pregnancy-associated plasma protein A (PAPP-A) levels as predictive factors of preeclampsia in the first trimester among Iranian women: a cohort study

  2019cites this paper